Home / Health / Human trial begins of Imperial College London's candidate Covid-19 vaccine

Human trial begins of Imperial College London's candidate Covid-19 vaccine

Imperial College London's vaccine candidate is being developed and trialled with the help of more than £41 million in funding from the UK government and a further £5 million in philanthropic donations

covid, coronavirus, vaccine, drug, pharma

Premium

The volunteer will receive a second booster dose within four weeks. Several others are expected to receive the first dose over the coming days

ANI

2 min read Last Updated : Jun 24 2020 | 9:05 AM IST

The human trial of Imperial College London's candidate coronavirus vaccine began on Tuesday with the first healthy volunteer receiving a small dose of it.

It is a second such trial in the UK. The first candidate vaccine that went for the human trial was from Oxford University.

The clinical team, which delivered a small dose of the vaccine to the participant at a West London facility, is closely monitoring the participant and report that they are in good health with no safety concerns, said the college in a press release.

The trials are the first test of a new self-amplifying RNA (saRNA) technology,

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in